Novavax | NVAX - Capital Ordinário





Capital Ordinário Alterar Data
Adma Biologics USD 232.29M 5.59M 2026-03
Agenus USD 38.52M 3.2M 2026-03
AstraZeneca USD 1.55B 44K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Cassava Sciences USD 48.31M 0 2026-03
Geron USD 640.9M 2.54M 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
MannKind USD 309.91M 1M 2026-06
Merck USD 2.47B 4.93M 2026-03
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.91B 60K 2026-03
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 105.62M 53K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06